CALC CalciMedica Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CALC

Price (delayed)

$1.79

Market cap

$12.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.7

Enterprise value

$2.81M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 3
Highlights
The quick ratio has grown by 3.3% YoY
The EPS has grown by 16% YoY but it has contracted by 3.9% from the previous quarter
The debt has grown by 37% since the previous quarter and by 8% year-on-year
CALC's equity is down by 10% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.graybug.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of CALC

CALC stock price

How has the CalciMedica stock price performed over time
Intraday
-4.28%
1 week
-9.6%
1 month
-37.41%
1 year
-88.56%
YTD
-94.57%
QTD
-65.24%

Financial performance

How have CalciMedica's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.63M
Net income
-$21.24M
Gross margin
N/A
Net margin
N/A
CALC's operating income is up by 22% year-on-year and by 12% since the previous quarter
CALC's net income is down by 9% QoQ

Price vs fundamentals

How does CALC's price correlate with its fundamentals

Growth

What is CalciMedica's growth rate over time

Valuation

What is CalciMedica stock price valuation
P/E
N/A
P/B
1.03
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 16% YoY but it has contracted by 3.9% from the previous quarter
CALC's price to book (P/B) is 47% lower than its 5-year quarterly average of 2.0
CALC's equity is down by 10% year-on-year

Efficiency

How efficient is CalciMedica business performance
The ROIC has plunged by 50% from the previous quarter and by 49% YoY
CalciMedica's return on assets has decreased by 45% YoY and by 8% QoQ

Dividends

What is CALC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CALC.

Financial health

How did CalciMedica financials performed over time
The total assets is 39% greater than the total liabilities
The total assets has surged by 127% since the previous quarter and by 2.2% year-on-year
The company's total liabilities rose by 44% QoQ and by 8% YoY
The debt is 67% greater than the equity
The debt to equity has soared by 128% since the previous quarter and by 20% year-on-year
The debt has grown by 37% since the previous quarter and by 8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.